Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea · Delayed Price · Currency is KRW 25,400
-1,900 (-6.96%)
Sep 22, 2026, 3:30 PM KST
Orum Therapeutics Revenue
Orum Therapeutics had revenue of 24.11M KRW in the quarter ending June 30, 2026, with 479.07% growth. This brings the company's revenue in the last twelve months to 40.55M, down -99.81% year-over-year. In the year 2025, Orum Therapeutics had annual revenue of 23.56M, down -99.89%.
Revenue (ttm)
40.55M
Revenue Growth
-99.81%
P/S Ratio
13,603.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
551.68B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.56M | -20.88B | -99.89% |
| Dec 31, 2024 | 20.91B | -114.51B | -84.56% |
| Dec 31, 2023 | 135.42B | 135.34B | 178,270.49% |
| Dec 31, 2022 | 75.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.